Felix Biotechnology
San Francisco
About Felix Biotechnology
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases. Felix Biotechnology's bio-therapeutics targets antibiotic-resistant bacteria to manage infectious diseases precisely and effectively, allowing healthcare professionals to manage urgent microbial challenges in human health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $720.4K
- Funding stage: Seed
- Last round: Grant (Jul 2022)
- Website: felixbt.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/felix-biotechnology-33176 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.